Regression of fibrosis and reversal of cirrhosis in rats by galectin inhibitors in thioacetamide-induced liver disease.
Galectin-3 protein is critical to the development of liver fibrosis because galectin-3 null mice have attenuated fibrosis after liver injury. Therefore, we examined the ability of novel complex carbohydrate galectin inhibitors to treat toxin-induced fibrosis and cirrhosis. Fibrosis was induced in ra...
Main Authors: | Peter G Traber, Hsin Chou, Eliezer Zomer, Feng Hong, Anatole Klyosov, Maria-Isabel Fiel, Scott L Friedman |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3793988?pdf=render |
Similar Items
-
Therapy of experimental NASH and fibrosis with galectin inhibitors.
by: Peter G Traber, et al.
Published: (2013-01-01) -
Cirrhosis induced by thioacetamide is prevented by stevia. Molecular mechanisms
by: Erika Ramos-Tovar, et al.
Published: (2019-01-01) -
Study of Thioacetamide Induced Liver Cirrhosis and Insulin Resistance in Rat
by: Chien-Yu Chu, et al.
Published: (2008) -
Histopathological evaluation of liver fibrosis and cirrhosis regression
by: Regina C. Lo, et al.
Published: (2017-12-01) -
Yoghurt dampened thioacetamide induced liver fibrosis in mice
by: Yan-Wen, Chen, et al.
Published: (2011)